In addition to above-mentioned treatment options, recurrent and metastatic HNSCC can be treated with immune checkpoint inhibitors (ICI) directed against programmed cell death protein-1 (PD-1). The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.